Versant Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1K Sell
749
-34
-4% -$407 ﹤0.01% 2229
2026
Q1
$4.69K Sell
783
-648
-45% -$4.88K ﹤0.01% 2403
2025
Q4
$10.3K Buy
1,431
+597
+72% +$4.72K ﹤0.01% 1981
2025
Q3
$8.91K Buy
834
+623
+295% +$6.11K ﹤0.01% 1981
2025
Q2
$2.04K Sell
211
-2,325
-92% -$24K ﹤0.01% 2374
2025
Q1
$37.8K Sell
2,536
-224
-8% -$3.44K 0.01% 988
2024
Q4
$41.2K Buy
2,760
+1,324
+92% +$21.6K 0.01% 663
2024
Q3
$27.5K Buy
1,436
+229
+19% +$4.75K 0.01% 675
2024
Q2
$25K Buy
1,207
+805
+200% +$16K 0.01% 628
2024
Q1
$7.56K Buy
402
+45
+13% +$772 ﹤0.01% 878
2023
Q4
$5.15K Buy
357
+297
+495% +$4.04K ﹤0.01% 955
2023
Q3
$1.04K Hold
60
﹤0.01% 1512
2023
Q2
$1.25K Sell
60
-35
-37% -$761 ﹤0.01% 1533
2023
Q1
$2.23K Sell
95
-2
-2% -$54 ﹤0.01% 1245
2022
Q4
$2.71K Buy
97
+5
+5% +$128 ﹤0.01% 1064
2022
Q3
$2K Sell
92
-4
-4% -$121 ﹤0.01% 1111
2022
Q2
$3K Hold
96
﹤0.01% 1012
2022
Q1
$3K Buy
96
+11
+13% +$376 ﹤0.01% 1053
2021
Q4
$3K Hold
85
﹤0.01% 1051
2021
Q3
$3K Buy
+85
New +$2.72K ﹤0.01% 1053

Other funds holding OGN

Versant Capital Management's OGN Position: Q2 2026 in Review

Versant Capital Management reduced its Organon & Co (OGN) stake by 4.3% in Q2 2026, selling an estimated $407 and leaving 749 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Versant Capital Management first reported a position in OGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $41.2K in Q4 2024. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Versant Capital Management held 749 shares of Organon & Co worth $10.1K as of Q2 2026.
  • Versant Capital Management sold 34 Organon & Co shares in Q2 2026, an estimated $407.
  • Organon & Co made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2229 holding.
  • Versant Capital Management first reported a position in Organon & Co in Q3 2021 and has held it in 20 quarters since.
  • Versant Capital Management's Organon & Co position peaked at $41.2K in Q4 2024.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.